I-Tadalafil 171596-29-5 iHormone kunye ne-endocrine unyango lwe-ED
Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Umthamo wemveliso:500kg/ngenyanga
Umyalelo(MOQ):25kg
Ixesha lokukhokhela:Iintsuku zokusebenza ezi-3
Imeko yokugcina:Igcinwe kwindawo epholileyo, eyomileyo, ubushushu begumbi.
Ipakethe imathiriyeli:igubu
Ubungakanani bepakethi:25kg/igubu
Ulwazi ngokhuseleko:Ayizompahla eziyingozi
Intshayelelo
I-Tadalafil, iyeza elisetyenziselwa ukunyanga i-erectile dysfunction (ED), i-benign prostatic hyperplasia (BPH), kunye ne-pulmonary arterial hypertension.
Inkcazo (USP42)
| Into | Inkcazo |
| Imbonakalo | Umgubo omhlophe okanye phantse omhlophe |
| Ukunyibilika | Inyibilika ngokukhululekileyo kwi-dimethyl sulfoxide, i-soluble kancinane kwi-methylene chloride kwaye ayinyibiliki ngokuthe ngqo emanzini. |
| Ukuchongwa | IR, HPLC |
| Ilahleko ekomisweni | ≤0.5% |
| Intsalela ekutshisweni | ≤0.10% |
| Ucoceko lwe-Enantiomeric kunye ne-Dia-stereomeric Ngu-HPLC | 6R,12aS Dia-stereomer ≤0.1% |
| 6S,12aS Enantiomer ≤0.1% | |
| 6S,12aR Dia-stereomer ≤0.1% | |
| Ubunyulu beChromatographic yi-HPLC | Ukungcola komntu ≤0.1% |
| Ubumdaka bubonke ≤0.3% | |
| Uvavanyo lwe-HPLC (kwisiseko somisiwe) | 97.5%~102.5% |
